Inovalon Holdings, Inc. - (INOV) Social Stream
Featured Post From StockTwits About INOV
$INOV [15s. delayed]: Issued Press Release on April 14, 07:55:00: Inovalon Announces First Quarter 2021 Earnings Conference Call https://s.flashalert.me/Snts1sfla, published April 14, 2021
Other Notable StockTweets About INOV
$INOV Colliers Securities Thinks INVO Bioscience’s Stock is Going to Recover.
March 30, 2021, 7:36 AM EDTSHARE ON:
In a report released today, Kyle Bauser from Colliers Securities reiterated a Buy rating on INVO Bioscience (INVO), with a price target of $6.00. The company’s shares closed last Monday at $4.24, close to its 52-week low of $2.80.
According to tipranks.com/, Bauser is a 4-star analyst with an average return of 13.7% and a 56.9% success rate. Bauser covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Inspire Medical Systems, and Chembio Diagnostics.
INVO Bioscience has an analyst consensus of Moderate Buy, with a price target consensus of $6.00.